Let’s get MSMEs to dream big, by ending their nightmare
The backbone of the economy needs much more than stopgap fixes
Ravi Venkatesan - August 26, 2020
Why EMs are more immune to COVID-19 disruption than DMs
GMO’s EM equity team makes a case for MSCI EM Index’s resilience and speedy recovery
July 30, 2020
Is there more upside in store for pharma stocks?
Over the past year, the Nifty Pharma Index has gained 23% while the Nifty has declined by 11%
June 30, 2020
Is it the right time to buy pharma stocks?
The Nifty Pharma Index is down 27% over the past year amid pricing and regulatory pressure
September 04, 2019
American lawyer James Rickards shares his 'efficient market hypothesis'
August 09, 2019
Have technology stocks run-up too far too fast?
While the NSE IT Index has gone up 20% in the past six months, earnings of IT firms have remained subdued
August 29, 2018
Is it an opportune time to invest in pharma stocks?
Over the past three years, the NSE Pharma Index has fallen 30% even as the benchmark Nifty rose 18%
June 20, 2018
Why are stock market prices so high?
GMO's Jeremy Grantham on how high profit margins and low inflation have driven the Dow Jones Index to an all-time high
Jeremy Grantham - August 09, 2017
Is the worst over for pharma stocks?
The pharma index has hugely underperformed the Sensex in CY17 owing to regulatory overhang and FDA issues
July 17, 2017
Is it time to move out of small and mid-cap stocks?
The valuation gap between S&P BSE Small Cap Index and the Sensex is at an all-time high
June 21, 2017